Long COVID Symptoms May Result in Cognitive Decline
Drug Topics
AUGUST 10, 2023
A study published in the Lancet found that patients who had previously tested positive for COVID-19 had lower cognitive accuracy compared to negative controls.
Drug Topics
AUGUST 10, 2023
A study published in the Lancet found that patients who had previously tested positive for COVID-19 had lower cognitive accuracy compared to negative controls.
PharmaVoice
AUGUST 10, 2023
July’s announcement from the beleaguered drugmaker signals the kind of shift the industry could see more of as M&A and IPOs tick up once again.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
AUGUST 10, 2023
After sessions end, head out to explore the city of San Diego.
Pharmacy Times
AUGUST 10, 2023
Findings may have therapeutic implications because of the potential to target neurotransmitters to treat or prevent melanoma.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
AUGUST 10, 2023
From outreach programs to point-of-care testing—and a solid online presence—here are a few ways to stand out from the crowd.
Pharmacy Times
AUGUST 10, 2023
Policy efforts must be put in place to support HCV treatment for all individuals to reduce the disparities in direct-acting antiviral treatment.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
AUGUST 10, 2023
Results of phase 3 trials could lead to the approval of remibrutinib to provide more effective and controlled treatment of chronic spontaneous urticaria than H1-antihistamines.
Board Vitals - Pharmacist
AUGUST 10, 2023
The journey to becoming a certified surgical technologist is a noble one, filled with dedication, perseverance, and a commitment to excellence. At the heart of this journey lies a crucial milestone – the NBSTSA Surgical Technology Exam. This comprehensive exam contains 175 questions (150 graded) with a pass rate of just 73.7% in 2020. How can you best prepare for the CST exam ?
Pharmacy Times
AUGUST 10, 2023
A variety of comorbid mood disorders often accompany this condition, including OCD and PTSD.
Fierce Healthcare
AUGUST 10, 2023
Insurers are set to receive $12.8B in MA bonus payments this year.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
AUGUST 10, 2023
There was no association between the amount of evidence behind a product and the time until Medicare coverage, suggesting issues within the coverage determination process itself.
Fierce Healthcare
AUGUST 10, 2023
Medicare Part D drug prices have increased by an average of 226% since market entry. These 25 drugs are responsible for $80.9 billion in total Part D spending in 2021. | A report from AARP broke down how popular brand-name drugs have continued to rise in price and exceed inflation.
Pharmacy Times
AUGUST 10, 2023
Approximately 57% of individuals who were shown a flowchart of the FDA vaccine approval process were very or somewhat likely to recommend a respiratory syncytial virus vaccine to a pregnant family member or friend compared to only 40% of those who were not shown the process.
European Pharmaceutical Review
AUGUST 10, 2023
The US Food and Drug Administration (FDA) has granted accelerated approval of TALVEY (talquetamab-tgvs) to treat multiple myeloma. Janssen Pharmaceutical Companies of Johnson & Johnson’s first-in-class bispecific T-cell engaging antibody showed an overall response rate (ORR) of over 70 percent in heavily pre-treated multiple myeloma. Based on this data, TALVEY is indicated for adults with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy, includin
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
AUGUST 10, 2023
No major changes were found in overdose behaviors among individuals who received take-home naloxone.
STAT
AUGUST 10, 2023
Carol Spence’s vision is flooded with green. As her brush swoops right and swishes left, she’s first transported to a lush spring meadow, then to the canopies of a rainforest — every stroke bringing her to another verdant utopia. Until she hears her daughter scream, “What are you doing?!
Pharmacy Times
AUGUST 10, 2023
Pharmacists also have the resources to help advocate for better care for patients.
STAT
AUGUST 10, 2023
WASHINGTON — Plenty of pharmaceutical executives have decried Democrats’ new drug pricing law as detrimental to the industry. But few are willing to say they may be willing to delay treatments for cancer patients if it means making more money. Genentech CEO Alexander Hardy, in an interview with STAT, explained that in the world that existed prior to the Inflation Reduction Act’s passage last year, drugmakers were incentivized to get drugs on the market as fast as possible, r
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Store News
AUGUST 10, 2023
Village Medical at Walgreens is a primary care practice located alongside a Walgreens pharmacy location.
STAT
AUGUST 10, 2023
As a new class of obesity medications has soared in popularity, so have the online outlets built to get them in the hands of patients. A new analysis of claims data from Trilliant Health suggests that collectively, telehealth companies — in particular, cash-pay options that market directly to consumers — could account for nearly half of the patients with insurance claims for GLP-1 prescriptions in 2022.
Fierce Healthcare
AUGUST 10, 2023
Mantra Health, a digital mental health provider for higher education, is joining forces with adolescent-focused Charlie Health to broaden access for students seeking higher levels of care. | The partners will connect college and university students who require a higher level of mental health care to Charlie Health’s virtual intensive outpatient program.
STAT
AUGUST 10, 2023
Anavex Life Sciences is in a tough spot. The serial dissembler of clinical trial results might be forced, finally, to tell the truth when it reads out its next study in Rett syndrome. What sets Anavex apart from all the other biotechs on my radar screen is its habit of shifting the goalposts on clinical trials. Twice last year, first in February and then in December , Anavex announced “positive” outcomes from studies of its drug called blarcamesine — except the results were
Fierce Healthcare
AUGUST 10, 2023
4 in 5 health plan execs are significantly concerned about rising GLP-1 utilization and costs, according to a newly | 4 in 5 health plan execs are significantly concerned about rising GLP-1 utilization and costs, according to a newly released survey from Virta Health.
STAT
AUGUST 10, 2023
Dan Worthley, a gastroenterologist and cancer scientist at Colonoscopy Clinic in Brisbane, Australia, does thousands of colonoscopies a year, seeking and destroying precancerous polyps. It’s a practically surefire way to prevent colorectal cancer, but an unpleasant experience for patients. The future, Worthley hopes, will be much less onerous — and he’s developing a technology that, if it works one day, might make the experience more of a piece of cake.
Drug Store News
AUGUST 10, 2023
Pharmacy legislation covering important issues, such as PBM reform and scope of practice, is gaining momentum at the state and federal levels. Here are the ones to watch.
The Honest Apothecary
AUGUST 10, 2023
Have you ever asked yourself this question: “What is the next step in my leadership journey?” It is a good question. Leadership is like climbing a mountain that has no pea or a ladder that has no top rung. Real leaders are generally hungry for the next challenge. They take a tough opportunity, give it their best, then start looking for the next giant to go after.
Fierce Healthcare
AUGUST 10, 2023
Sutter Health logged a $29 million operating income (0.8% operating margin) and $265 million bottom line for the quarter ended June 30, thanks in part to higher patient volumes and their accompanyi | The California nonprofit system's 0.8% operating margin and $265 million net income are clear improvements over the previous year's performance.
STAT
AUGUST 10, 2023
As demand for Ozempic and Wegovy surges, a little-noticed warning about the medicines was issued recently by regulators. In late May, the Food and Drug Administration said it received a “few” adverse event reports concerning compounded versions of the injectable medicines, which both contain the same active ingredient, known as semaglutide.
pharmaphorum
AUGUST 10, 2023
Babylon closes US business as rescue merger deal fails Phil.
STAT
AUGUST 10, 2023
ST. LOUIS — Firefighter and paramedic Mike Camilleri once had no trouble hauling heavy gear up ladders. Now battling long Covid, he gingerly steps onto a treadmill to learn how his heart handles a simple walk. “This is, like, not a tough-guy test so don’t fake it,” warned Beth Hughes, a physical therapist at Washington University in St.
BioPharm
AUGUST 10, 2023
The site was acquired by AGC Biologics in July 2020, and the Milan location is the first cell and gene therapy site approved in Europe for GMP manufacturing of clinical and commercial supplies.
pharmaphorum
AUGUST 10, 2023
Novo Nordisk buys Inversago for $1bn as Wegovy sales soar Phil.
Drug Store News
AUGUST 10, 2023
The winning artist will receive a tuition scholarship and their design featured on Schick Intuition packaging.
Let's personalize your content